Intern I - Software Test Development Engineering jobs in United States
cer-icon
Apply on Employer Site
company-logo

Dexcom · 1 day ago

Intern I - Software Test Development Engineering

Dexcom Corporation is a pioneer in continuous glucose monitoring, aiming to empower people to take control of their health. They are seeking an Intern I in Software Test Development Engineering to work on automation of testing solutions while collaborating with engineers on impactful projects. This internship offers hands-on experience in a mission-driven environment focused on healthcare technology.

DiabetesHealth DiagnosticsMedical DeviceSensor
check
H1B Sponsor Likelynote

Responsibilities

You will be working on a targeted project to explore, start and complete
You will be working directly with the engineers on the team
You will be designing a solution to automate an area of testing
You will be writing code on a regular basis

Qualification

PythonAI developmentGCPCommunicationCollaboration

Required

Requires a high school diploma/certificate or equivalent
Must be a currently enrolled student at an accredited college or university in a STEM discipline with an expected graduation date of December 2026 or later
You must be able to write code
You must be able to communicate with other engineers and developers, to learn, understand the problem, and collaborate on a solution

Preferred

Experience with Python is a plus
Experience with AI development is a plus
Experience or knowledge of GCP is a plus

Benefits

Paid Holidays
Social Events
Intern Recognition Awards

Company

Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.

H1B Sponsorship

Dexcom has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (41)
2023 (67)
2022 (75)
2021 (49)
2020 (36)

Funding

Current Stage
Public Company
Total Funding
$2.16B
Key Investors
RWI Group
2023-05-02Post Ipo Debt· $1B
2020-05-12Post Ipo Debt
2018-11-01Post Ipo Equity· $750M

Leadership Team

leader-logo
Jacob Leach
Chief Operating Officer
linkedin
leader-logo
Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs
linkedin
Company data provided by crunchbase